NASDAQ:PETS - Petmed Express Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$35.26 -0.32 (-0.90 %)
(As of 09/25/2018 04:00 PM ET)
Previous Close$35.45
Today's Range$35.24 - $35.56
52-Week Range$31.81 - $57.80
Volume20,174 shs
Average Volume417,724 shs
Market Capitalization$747.37 million
P/E Ratio19.41
Dividend Yield2.99%
Beta0.55
Petmed Express logoPetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins and nutritional supplements, and hygiene products. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, antibiotics and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Pompano Beach, FL.

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Debt-to-Equity RatioN/A
Current Ratio4.41
Quick Ratio3.52

Price-To-Earnings

Trailing P/E Ratio19.41
Forward P/E Ratio15.46
P/E GrowthN/A

Sales & Book Value

Annual Sales$273.80 million
Price / Sales2.66
Cash Flow$1.8666 per share
Price / Cash18.89
Book Value$5.62 per share
Price / Book6.27

Profitability

EPS (Most Recent Fiscal Year)$1.82
Net Income$37.28 million
Net Margins14.42%
Return on Equity35.77%
Return on Assets29.63%

Miscellaneous

Employees187
Outstanding Shares20,690,000
Market Cap$747.37 million

Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express announced a quarterly dividend on Monday, July 23rd. Investors of record on Friday, August 3rd will be paid a dividend of $0.27 per share on Friday, August 10th. This represents a $1.08 annualized dividend and a yield of 3.06%. The ex-dividend date is Thursday, August 2nd. This is an increase from Petmed Express's previous quarterly dividend of $0.25. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) issued its earnings results on Monday, July, 23rd. The company reported $0.62 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.63 by $0.01. The business had revenue of $87.39 million for the quarter, compared to analyst estimates of $85.72 million. Petmed Express had a return on equity of 35.77% and a net margin of 14.42%. The business's quarterly revenue was up 9.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.45 EPS. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Monday, October, 22nd 2018. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

5 brokers have issued twelve-month price objectives for Petmed Express' shares. Their forecasts range from $19.00 to $58.00. On average, they anticipate Petmed Express' share price to reach $36.3333 in the next year. This suggests a possible upside of 3.0% from the stock's current price. View Analyst Price Targets for Petmed Express.

What is the consensus analysts' recommendation for Petmed Express?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.

Who are some of Petmed Express' key competitors?

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Menderes Akdag, President, Chief Executive Officer & Director
  • Bruce S. Rosenbloom, Treasurer, Chief Financial & Accounting Officer
  • Alison Berges, Secretary & General Counsel

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.10%), Renaissance Technologies LLC (7.99%), Epoch Investment Partners Inc. (2.42%), Bank of New York Mellon Corp (1.63%), Bank of New York Mellon Corp (1.63%) and Northern Trust Corp (1.38%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which institutional investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including Federated Investors Inc. PA, Bank of America Corp DE, Fisher Asset Management LLC, ClariVest Asset Management LLC, GSA Capital Partners LLP, Canada Pension Plan Investment Board, Bank of New York Mellon Corp and Bank of New York Mellon Corp. Company insiders that have sold Petmed Express company stock in the last year include Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for Petmed Express.

Which institutional investors are buying Petmed Express stock?

PETS stock was bought by a variety of institutional investors in the last quarter, including Epoch Investment Partners Inc., Newtyn Management LLC, BlackRock Inc., Scout Investments Inc., LSV Asset Management, Carillon Tower Advisers Inc., TD Asset Management Inc. and Capital Fund Management S.A.. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $35.26.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $747.37 million and generates $273.80 million in revenue each year. The company earns $37.28 million in net income (profit) each year or $1.82 on an earnings per share basis. Petmed Express employs 187 workers across the globe.

What is Petmed Express' official website?

The official website for Petmed Express is http://www.1800petmeds.com.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (NASDAQ PETS)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  131 (Vote Outperform)
Underperform Votes:  285 (Vote Underperform)
Total Votes:  416
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel